Home Cart 0 Sign in  
X

[ CAS No. 3420-02-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3420-02-8
Chemical Structure| 3420-02-8
Chemical Structure| 3420-02-8
Structure of 3420-02-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3420-02-8 ]

Related Doc. of [ 3420-02-8 ]

Alternatived Products of [ 3420-02-8 ]

Product Details of [ 3420-02-8 ]

CAS No. :3420-02-8 MDL No. :MFCD00005682
Formula : C9H9N Boiling Point : -
Linear Structure Formula :- InChI Key :ONYNOPPOVKYGRS-UHFFFAOYSA-N
M.W : 131.17 Pubchem ID :137928
Synonyms :
6-Methylindole

Calculated chemistry of [ 3420-02-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.11
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.26
TPSA : 15.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.7
Log Po/w (XLOGP3) : 3.32
Log Po/w (WLOGP) : 2.48
Log Po/w (MLOGP) : 1.89
Log Po/w (SILICOS-IT) : 3.06
Consensus Log Po/w : 2.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.41
Solubility : 0.0509 mg/ml ; 0.000388 mol/l
Class : Soluble
Log S (Ali) : -3.33
Solubility : 0.0616 mg/ml ; 0.00047 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.63
Solubility : 0.0305 mg/ml ; 0.000232 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 3420-02-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3420-02-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3420-02-8 ]
  • Downstream synthetic route of [ 3420-02-8 ]

[ 3420-02-8 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 3420-02-8 ]
  • [ 5649-36-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 24, p. 9480 - 9497
  • 2
  • [ 3420-02-8 ]
  • [ 209920-43-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 11, p. 2734 - 2737
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 17, p. 7293 - 7316
[3] Patent: WO2009/125923, 2009, A2,
  • 3
  • [ 3420-02-8 ]
  • [ 68-12-2 ]
  • [ 4771-49-7 ]
YieldReaction ConditionsOperation in experiment
94%
Stage #1: at 0 - 20℃; for 1.5 h;
Stage #2: for 1.5 h; Heating / reflux
Example 4; 1. Synthesis of indole derivatives; 1) Synthesis of 3-cyanoindole derivatives; [Show Image] Nine objective compounds were prepared by (1) formylation of 3-position of the corresponding indole using phosphorus oxychloride in the presence of dimethylformamide (Vilsmeier method), (2) cyanation by dehydrating reaction with hydroxylamine in sodium formate and formic acid, (3) coupling with ethyl 4-fluorobenzoate in the presence of potassium fluoride on almina and 18-crown-6-ether in dimethyl sulfoxide and then, (4) hydrolysis with lithium hydroxide in total 4 steps in that order (the following Table 2). In addition, XO-CH172 and XO-CH183 (R is a 2-methyl group or a 5-methoxy group, respectively) were prepared from the step (2) using the corresponding aldehydes purchased.; 1) Synthesis of XO-CH200; XO-CH180 Under an argon atmosphere, 6-methylindole (1.004 g, 7. 62 mmol) was dissolved in dimethylformamide (10 mL), and to the solution was added phosphorus oxychloride (2 mL) under ice-cooling. The mixture was stirred for 1.5 hours at room temperature. To the reaction mixture was added dropwise an aqueous sodium hydroxide solution (5g/15mL) under ice-cooling. The mixture was heated for reflux for 1.5 hours. To the reaction mixture was added water under ice-cooling, and the mixture was adjusted to pH3 with concentrated hydrochloric acid. The solid was collected by filtration and dried at 60°C under reduced pressure to give XO-CH180 as a pale brown solid (1.14 g, 94percent yield).
79%
Stage #1: at 0℃;
Stage #2: at 35℃; for 1 h;
General procedure: The Vilsmeier-Haack reagent was prepared by adding POCl3 (60 mmol, 6 mL) dropwise to ice-cold dry DMF (30 mL) whilst stirring. The mixture was then stirred for 10-15 min at 0 °C. Compound 3b or 3e (10 mmol) was added as a solution in DMF (5 mL) to the above Vilsmeier-Haack reagent. The stirred mixture was then heated at 35 °C for 1 h. After cooling, ice water (6 mL) and a 30percent aqueous solution of NaOH (13 mL) were added successively, and the mixture was heated at reflux for 20 min and allowed to cool. The mixture was extracted with CH2Cl2 (20 mL*3). The extracts were dried over Na2SO4, evaporated under reduced pressure to remove the solvent, and the crude product was purified by flash column chromatography using 15-25percent acetone/petroleum ether (60-90 °C) as eluent to give the corresponding intermediate compound 4b or 4e, respectively.
Reference: [1] Journal of Agricultural and Food Chemistry, 2013, vol. 61, # 24, p. 5696 - 5705
[2] Patent: EP1932833, 2008, A1, . Location in patent: Page/Page column 15; 19
[3] Chemical Biology and Drug Design, 2011, vol. 78, # 5, p. 864 - 868
[4] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 776 - 783
[5] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 7, p. 1301 - 1305
[6] Patent: US5563147, 1996, A,
[7] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 7, p. 3780 - 3790
[8] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 24, p. 7274 - 7277
[9] Angewandte Chemie - International Edition, 2013, vol. 52, # 11, p. 3250 - 3254[10] Angew. Chem., 2013, vol. 125, # 11, p. 3332 - 3336,5
[11] Organic Letters, 2015, vol. 17, # 12, p. 3186 - 3189
[12] Chemistry - A European Journal, 2015, vol. 21, # 43, p. 15104 - 15107
[13] Organic Letters, 2017, vol. 19, # 10, p. 2502 - 2505
[14] Chemical Communications, 2017, vol. 53, # 43, p. 5834 - 5837
  • 4
  • [ 3420-02-8 ]
  • [ 100-97-0 ]
  • [ 4771-49-7 ]
YieldReaction ConditionsOperation in experiment
91% With iodine; oxygen; pyrographite In N,N-dimethyl-formamide at 120℃; for 0.8 h; General procedure: A 50 mL round bottom flask equipped with a magnetic stirring bar was charged with substituted indole 1 (1.0 mmol, 1.0 equiv), HMTA (2.0 mmol, 0.2803 g, 2.0 equiv), activated carbon (0.1 g) and DMF (2 mL). Then I2 (0.2 mmol, 0.0507g, 20 molpercent) was added and the flask was equipped with a reflux condenser. The reaction mixture was stirred at 120 oC under open air and monitored by TLC. Upon completion of the reaction, the reaction mixture was cooled to room temperature. The resultant mixture was filtered through a pad of celite and the filter cake was washed thoroughly with EtOAc (4 × 6 mL). The filtrate was washed with 0.5 M aqueous HCl (10 mL), saturated NaHCO3 solution (10 mL) and saturated NaCl solution ( 10 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel eluted with hexane and ethyl acetate to give the product.
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 30, p. 2877 - 2880
  • 5
  • [ 3420-02-8 ]
  • [ 50-00-0 ]
  • [ 4771-49-7 ]
YieldReaction ConditionsOperation in experiment
92% With iron(III) chloride; ammonia In water; N,N-dimethyl-formamide at 130℃; for 1 h; General procedure: A 50 mL round-bottomed flask equipped with a magnetic stirringbar was charged with the appropriate indole 1 (0.5 mmol,1.0 equiv), 37percent aq HCHO (0.5 mmol, 0.0406 g, 1.0 equiv), 25percent aqNH3 (1.0 mmol, 0.0681 g, 2.0 equiv), FeCl3 (0.01 mmol, 0.0016 g,2 molpercent), and DMF (2 mL). The flask was fitted with a reflux condenser,and the mixture was stirred at 130 °C under open air.When the reaction was complete (TLC), the mixture was cooledto r.t., diluted with sat. aq NaCl (10 mL) and 0.5 M aq HCl (2 mL),and extracted with EtOAc (3 x 7 mL). The organic layers werecombined, washed with sat. aq NaHCO3 (10 mL) and sat. aq NaCl(10 mL), dried (Na2SO4), and concentrated under reduced pressure.The residue was purified by flash column chromatography(silica gel, hexane–EtOAc).
Reference: [1] Synlett, 2017, vol. 28, # 19, p. 2670 - 2674
  • 6
  • [ 3420-02-8 ]
  • [ 1196-70-9 ]
Reference: [1] Tetrahedron Letters, 1989, vol. 30, # 45, p. 6117 - 6120
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 3420-02-8 ]

Indoles

Chemical Structure| 5649-36-5

[ 5649-36-5 ]

2,6-Dimethyl-1H-indole

Similarity: 0.97

Chemical Structure| 5318-27-4

[ 5318-27-4 ]

6-Aminoindole

Similarity: 0.97

Chemical Structure| 30877-30-6

[ 30877-30-6 ]

5,6-Dimethyl-1H-indole

Similarity: 0.97

Chemical Structure| 196205-06-8

[ 196205-06-8 ]

4-Methyl-1H-indol-5-amine

Similarity: 0.94

Chemical Structure| 16096-32-5

[ 16096-32-5 ]

4-Methyl-1H-indole

Similarity: 0.94